- Net Sales for Q1FY12 at Rs. 52.25 crore, up 29.14%
- Net Profit for Q1FY12 jumps 28.74% at Rs. 13.59 crore
- EPS for Q1FY12 stood at Rs. 1.32 as against Rs. 1.02 in Q1FY11
Bliss GVS Pharma Limited, the Mumbai-based fast growing export-oriented pharmaceutical company reported a jump of 28.74% in it Net Profit to Rs 13.59 crore as against Rs 10.55 crore recorded in the same period of last fiscal.
Net Sales during the quarter rose by 29.14% to Rs. 52.25 crore as against Rs 40.45 crore reported in Q1FY11. Earnings per share for the quarter ended June 30, 2011 works out to Rs. 1.32 as against Rs. 1.02 in quarter ended June 30th, 2010.
The EBIDTA (includes other income) for the quarter stood at Rs. 19.35 crore as compared to Rs. 13.79 crore during the same period last year, a rise of 40.32%. The EBIDTA margin for Q1FY12 rose to 37.03% from 34.08% in the same period last year.